3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1/2
1
Phase 1
1
Status
Recruiting
3
Completed
2
Not yet recruiting
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Carcinoma, Non-Small-Cell Lung
37
Colorectal Neoplasms
28
Leukemia, Myeloid, Acute
27
Neoplasms
26
Recurrence
22
Neoplasm Metastasis
22
Multiple Myeloma
20
Advanced Solid Tumors
20
Lymphoma, B-Cell
19
Breast Neoplasms
17
Pancreatic Neoplasms
14
Lung Neoplasms
13
Glioblastoma
13
Carcinoma, Hepatocellular
13
Brain Neoplasms
13
Lymphoma
12
Glioma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
11
Melanoma
11
Hematologic Neoplasms
11
Triple Negative Breast Neoplasms
10
Squamous Cell Carcinoma of Head and Neck
10
Ovarian Neoplasms
10
Leukemia
10
Advanced Solid Tumor
10
Prostatic Neoplasms
9
Head and Neck Neoplasms
9
Lymphoma, Non-Hodgkin
8
Esophageal Neoplasms
8
Sarcoma
7
Interventions
cabozantinib
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Not yet recruiting
×
Neurofibroma, Plexiform
×
Clear all
NCT06502171
2026-03-12
NF113
University of Alabama at Birmingham
Phase 1
Not yet recruiting
30 enrolled